Skip to main content

Table 2 Characteristics of study participants with and without MetS

From: A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy

 

MetS (n =  29)

No MetS (n =  60)

P value

Age (years)

49 ± 4

48 ± 8

0.54

Sex (%)

   

Male

12 (41)

29 (48)

0.35

Female

17 (59)

31 (52)

 

Duration of HIV (years)

17 ± 7

18 ± 15

0.32

ART (%)

   

PI

22 (78)

24 (44)

0.003

Non-PI

6 (21)

30 (55)

 

Ethnicity (%)

  

0.41

Non-Hispanic White

1 (3)

9 (15)

 

African-American

22 (76)

36 (60)

 

Hispanic

6 (21)

15 (25)

 

Employment (%)

  

0.11

Unemployed

26 (93)

48 (80)

 

Employed (part or full time)

2 (7)

12 (20)

 

Systolic BP (mmHg)

132 ± 13

122 ± 10

0.000

Diastolic BP (mmHg)

84 ± 9

78 ± 8

0.002

Body mass index (kg/m2)

31.8 ± 7.0

31.0 ± 8.2

0.64

Waist circumference (cm)

108 ± 15.0

105 ± 20

0.46

Waist-hip ratio

0.93 ± 0.07

0.92 ± 0.07

0.38

VO2max (ml/kg/min)

26.5 ± 7.7

27.3 ± 8.4

0.76

1-RM upper body (lbs)

112 ± 49

117 ± 53

0.69

1-RM lower body (lbs)

209 ± 93

232 ± 71

0.24

Current coffee drinker (%)

20 (77)

47 (78)

0.34

Current alcohol drinker (%)

6 (21)

16 (27)

0.54

Current smoker (%)

9 (31)

23 (38)

0.50

Sleep (hours)

6.5 ± 1.7

7 ± 1.8

0.70

  1. Data are means ± SD or n (%).
  2. MetS metabolic syndrome, ART antiretroviral therapy, PI protease inhibitors, BP blood pressure, VO 2max maximal oxygen consumption, 1-RM one repetition maximum.